These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28674022)

  • 1. FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.
    Liu T; Zhang H; Sun L; Zhao D; Liu P; Yan M; Zaidi N; Izadmehr S; Gupta A; Abu-Amer W; Luo M; Yang J; Ou X; Wang Y; Bai X; Wang Y; New MI; Zaidi M; Yuen T; Liu C
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7683-7688. PubMed ID: 28674022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization.
    Yan M; Wang J; Ren Y; Li L; He W; Zhang Y; Liu T; Li Z
    Cell Death Dis; 2019 Feb; 10(3):204. PubMed ID: 30814489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSIP1 regulates autophagy in breast cancer.
    Liu C; Sun L; Yang J; Liu T; Yang Y; Kim SM; Ou X; Wang Y; Sun L; Zaidi M; New MI; Yuen T; Guo Q
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13075-13080. PubMed ID: 30509973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSIP1 is correlated with estrogen receptor status and poor prognosis.
    Li X; Song X; Ma J; Zhao Y; Jiang Q; Zhao Z; Li M
    Mol Carcinog; 2020 Jan; 59(1):126-135. PubMed ID: 31713931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of cancer/testis antigen FSIP1 in ER-positive breast tumors.
    Chapman KB; Prendes MJ; Kidd JL; Sternberg H; West MD; Wagner J
    Biomark Med; 2013 Aug; 7(4):601-11. PubMed ID: 23905897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer.
    Hung SW; Chiu CF; Chen TA; Chu CL; Huang CC; Shyur LF; Liang CM; Liang SM
    Breast Cancer Res Treat; 2012 Nov; 136(1):89-105. PubMed ID: 22983836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells.
    Xiong L; Ding L; Ning H; Wu C; Fu K; Wang Y; Zhang Y; Liu Y; Zhou L
    Oncotarget; 2016 Sep; 7(36):57737-57751. PubMed ID: 27363028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinicopathological significance of FSIP1 in breast cancer.
    Zhang H; Luo M; Jin Z; Wang D; Sun M; Zhao X; Zhao Z; Lei H; Li M; Liu C
    Oncotarget; 2015 Apr; 6(12):10658-66. PubMed ID: 25826084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
    Chen G; Sun L; Gu X; Ai L; Yang J; Zhang Z; Hou P; Wang Y; Ou X; Jiang X; Qiao X; Ma Q; Niu N; Xue J; Zhang H; Yang Y; Liu C
    Sci China Life Sci; 2023 Dec; 66(12):2805-2817. PubMed ID: 37460715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
    Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
    Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu.
    Piechocki MP; Yoo GH; Dibbley SK; Lonardo F
    Cancer Res; 2007 Jul; 67(14):6825-43. PubMed ID: 17638894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.
    Ai M; Liang K; Lu Y; Qiu S; Fan Z
    Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
    Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
    Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
    Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
    J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
    Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
    Kong Q; Qiu M
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.